| Literature DB >> 20924115 |
Sabina Sangaletti1, Claudio Tripodo, Chiara Ratti, Silvia Piconese, Rossana Porcasi, Rosalba Salcedo, Giorgio Trinchieri, Mario P Colombo, Claudia Chiodoni.
Abstract
Oncogene activation promotes an intrinsic inflammatory pathway that is crucial for cancer development. Here, we have investigated the actual effect of the inflammatory cytokine tumor necrosis factor (TNF) on the natural history of spontaneous mammary cancer in the HER2/neuT (NeuT) transgenic mouse model. Bone marrow transplantation from TNF knockout mice into NeuT recipients significantly impaired tumor growth, indicating that the source of TNF fostering tumor development was of bone marrow origin. We show that the absence of leukocyte-derived TNF disarranged the tumor vasculature, which lacked pericyte coverage and structural integrity, leading to diffuse vascular hemorrhage and stromal necrosis. In addition, tumor-associated Tie2-expressing monocytes were reduced and cytokine expression skewed from Th2 to Th1 type. Treatment of NeuT mice with anti-TNF antibody partially phenocopied the antitumor effect of TNF-deficient bone marrow cell transplantation, providing a strong preclinical background and rationale for the introduction of TNF antagonists in the treatment of human breast cancer, including basal-like samples for which consolidated targeted therapies do not exist. ©2010 AACR.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20924115 PMCID: PMC7371347 DOI: 10.1158/0008-5472.CAN-10-0471
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701